Search
Outlook Therapeutics Inc
OTLKAdd to Watchlist
1.580USD
-0.070-4.24%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
102.00MMarket Cap
LossP/E TTM
Outlook Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Outlook Therapeutics Inc is 9.15, ranking 55 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.40, which is -135.52% below the recent high of 0.50 and -444.13% above the recent low of -7.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
